Comparison of Operated Ruptured and Non-ruptured Endometriomas (RupturedOMA)

April 21, 2022 updated by: MD. Ayşe Gülen Erturun, EZH EAH

Comparison of Inflammatory Parameters in Operated Ruptured and Non-ruptured Endometriomas

Ruptured endometrioma cases were compared with unruptured endometrioma cases.

Study Overview

Detailed Description

This study aims to compare the findings in patients who had surgery for ruptured endometrioma with the patients who had an unruptured endometrioma.

This study was conducted at Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic and all patients who were operated for endometrioma and had a histopathology report confirming the presence of endometrioma between January 2014 and December 2020 were included.

In this study, demographic characteristics, intraoperative findings, laboratory values and follow-up recommendations of two groups compared. The patients' age, presence of sexual activity and/or infertility, gravidity, parity, abortion, history of ectopic pregnancy, accompanying systemic disease, previous operations, drug use, and symptoms were recorded. Preoperative and postoperative complete blood count, Cancer antigen 125 (CA 125), Cancer antigen 19-9 (CA19-9), Cancer antigen 15-3 (CA 15-3), Carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), anti mullerian hormone (AMH), fibrinogen, C-reactive protein (CRP) values of the patients were obtained. Patient files, operation notes and laboratory values of the electronic recording system database and the two groups were compared.

Study Type

Observational

Enrollment (Actual)

181

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Keçiören
      • Ankara, Keçiören, Turkey, 06050
        • Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 48 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients who were operated on in Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic, whose histopathological diagnosis was confirmed as endometrioma. All patients were women of reproductive age with a pelvic mass.

Description

Inclusion Criteria:

  • All patients who were operated on in Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic, whose histopathological diagnosis was confirmed as endometrioma, and who did not meet the exclusion criteria, were included in the study.

Exclusion Criteria:

  • Patients who were operated with a prediagnosis of endometrioma and whose pathological diagnosis was different
  • Patients with smoking, alcohol, substance abuse
  • Patients receiving pelvic radiotherapy/chemotherapy
  • Patients with suspected or confirmed malignancies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Operated Non-Ruptured Endometrioma Group
It consists of patients who were found to have endometrioma in their clinical follow-ups and decided to operate as a result of the evaluations. The patients were operated under elective conditions.
All patients included in the study were operated patients.
Operated Ruptured Endometrioma Group
Rupture of endometrioma, which is a rare gynecological emergency. This group consists of endometrioma patients requiring urgent/subacute operation such as acute abdominal pain, hemodynamic instability, intra-abdominal bleeding. The patients were operated after completing the necessary preparations
All patients included in the study were operated patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pre-interventional Comparison of inflammatory parameters
Time Frame: Blood samples were taken from the patients before the surgery
Neutrophil/Lymphocyte ratio (NLR), Platelet/Lymphocyte ratio (PLR), Monocyte/Lymphocyte ratio (MLR) were compared between two groups in the preoperative period
Blood samples were taken from the patients before the surgery
Comparison of inflammatory parameters after surgery
Time Frame: Blood samples were taken from the patients in the first postoperative day.
Neutrophil/Lymphocyte ratio (NLR), Platelet/Lymphocyte ratio (PLR), Monocyte/Lymphocyte ratio (MLR) were compared between two groups in the postoperative period
Blood samples were taken from the patients in the first postoperative day.
Pre-interventional Comparison of tumor markers
Time Frame: Blood samples were taken from the patients before the surgery
Cancer antigens; CA125, CA19-9 and CA 15-3 were compared between two groups in the preoperative period
Blood samples were taken from the patients before the surgery
Comparison of tumor markers after surgery
Time Frame: Blood samples were taken from the patients after the surgery up to 24 weeks
Cancer antigens; CA125, CA19-9 and CA 15-3 were compared between two groups in the postoperative period
Blood samples were taken from the patients after the surgery up to 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual activity
Time Frame: Before surgery
The existence of sexual activity in each study group was questioned.
Before surgery
Infertility
Time Frame: Before surgery
The existence of infertility in each study group was questioned.
Before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Berna Dilbaz, Prof., Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic's Chief

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2014

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

June 20, 2021

Study Registration Dates

First Submitted

January 25, 2022

First Submitted That Met QC Criteria

April 21, 2022

First Posted (Actual)

April 27, 2022

Study Record Updates

Last Update Posted (Actual)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 21, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/76

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometrioma

Clinical Trials on Laparoscopy/Laparotomy

3
Subscribe